Skip to main content
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD logo

BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD — Investor Relations & Filings

Ticker · 000931 ISIN · CNE000001030 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,999 across all filing types
Latest filing 2024-12-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000931

About BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD

https://www.centek.com.cn

Beijing Centergate Technologies (Holding) Co., Ltd. focuses on the research, development, production, and distribution of medical and healthcare products. The company’s core operations involve the manufacturing of chemical pharmaceuticals, traditional Chinese medicines, and health supplements. Its product portfolio addresses various therapeutic areas, including cardiovascular health, digestive system treatments, and anti-infective therapies. Additionally, the company provides healthcare services and develops medical devices. Through its specialized subsidiaries, it maintains integrated research and manufacturing capabilities aimed at providing clinical solutions and health management products. The organization emphasizes technological advancement and quality control across its supply chain to meet diverse patient needs and healthcare standards.

Recent filings

Filing Released Lang Actions
关于下属公司山东华素取得实用新型专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a subsidiary company obtaining a utility model patent certificate. It is a brief notice about intellectual property rights and does not contain financial data, management changes, or regulatory filings related to financial performance. It is not an annual report, earnings release, or any detailed financial or governance report. It is a regulatory announcement about a patent certificate, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-12-18 Chinese
关于药品进入国家医保目录（2024年）的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Beijing Zhongguancun Technology Development (Holdings) Co., Ltd. regarding the inclusion of its pharmaceutical products in the 2024 National Medical Insurance Drug Catalog. It details the products included, their specifications, and related regulatory information. The document is an official announcement about a regulatory update affecting the company's products, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. It is not a report publication announcement since it contains substantive content rather than just a notice of report availability. The document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about product inclusion in a government insurance catalog, which is material information for investors but does not fall under other specific categories.
2024-12-11 Chinese
关于公司副总裁辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's vice president. It includes details about the resignation, the effective date, and the impact on the company. There is no financial data, no mention of a report or meeting materials, and it concerns a change in senior management. According to the filing definitions, announcements about changes in the company's board of directors or senior management fall under 'Board/Management Information' (MANG). The document length is short and focused solely on management change, confirming this classification.
2024-12-04 Chinese
关于下属公司多多药业非布司他片收到国家药品监督管理局《受理通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1170 characters) about a subsidiary company receiving an acceptance notice from the National Medical Products Administration for a drug registration application. It is an official announcement of a regulatory acceptance event, not a financial report or detailed filing. The document does not contain financial statements, management discussion, or detailed report data. It is not a report publication announcement since it is the announcement itself. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-11-12 Chinese
关于盐酸哌甲酯缓释咀嚼片项目的进展公告
Regulatory Filings Classification · 95% confidence The document is titled as a progress announcement regarding a specific project related to a pharmaceutical patent. It details the signing of a technology transfer contract, patent rights acquisition, and regulatory approvals. The document is short (1331 characters) and serves as an update on the progress of a project rather than a full financial or operational report. It does not contain financial statements, earnings data, or detailed management analysis. It is an announcement of project progress and patent-related developments, fitting the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2024-11-12 Chinese
关于下属公司北京华素取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a subsidiary company obtaining an invention patent certificate. It includes details about the patent, such as application date, authorization date, patent number, and patent holder. There is no financial data, no mention of financial results, management changes, or regulatory filings. The document is a formal announcement of a patent grant, which is a regulatory announcement but does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it is not about a report. The best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about intellectual property.
2024-11-12 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.